Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Opioid Analgesics: Morphine and Other Natural Cogeners

Opioid Analgesics: Morphine and Other Natural Cogeners

Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...

Opioid Analgesics: Synthetic and Semisynthetic Opioids

Opioid Analgesics: Synthetic and Semisynthetic Opioids

Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...

Analgesia and Pain Management

Analgesia and Pain Management

Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...

Opioid Receptors: Overview

Opioid Receptors: Overview

Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2, D-Pen5]-enkephalin or DPDPE for...

Pharmaceutical Alternatives: Polymorphic Form-Related and Particle Size-Related Therapeutic Nonequivalence

Pharmaceutical Alternatives: Polymorphic Form-Related and Particle Size-Related Therapeutic Nonequivalence

Changes in polymorphic forms can significantly influence the bioavailability of poorly soluble drugs. Although the FDA defines pharmaceutical equivalence based on having the same active ingredient, dosage form, and route of administration, it does not automatically disqualify products with different polymorphic forms. This means two products with different polymorphs can still be deemed pharmaceutically equivalent. However, polymorphic differences can affect properties like wettability,...

Drugs Affecting GI Tract Motility: Opioids as Antidiarrheal Agents

Drugs Affecting GI Tract Motility: Opioids as Antidiarrheal Agents

Diarrhea, a condition marked by frequent loose or watery bowel movements, can be triggered by multiple factors such as viral or bacterial infections, food intolerances, anxiety, medications, and digestive disorders. Symptoms may include abdominal pain, bloating, nausea, and cramping. Severe or prolonged diarrhea can lead to complications like electrolyte imbalances, malnutrition, and dehydration if left untreated.
Opioids, widely used antidiarrheal agents, mitigate diarrhea by slowing down...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

A 1000-Fold Fentanyl Dosing Error Across Five Editions of the Grossman Baim Cardiac Catheterization Literature.

Journal of patient safety·2026

Same author

Medical Students and Clinicians' Perceptions of Social Media Direct-to-Consumer Advertising and Medication Requests.

JMIR formative research·2026

Same author

Harassment charges: Enough himpathy.

Science (New York, N.Y.)·2018

Same author

Journal editors should not divide scientists.

Science (New York, N.Y.)·2018

Search research articles

Related Experiment Video

Updated: Jul 4, 2026

Demonstration of the Sequence Alignment to Predict Across Species Susceptibility Tool for Rapid Assessment of Protein Conservation

Demonstration of the Sequence Alignment to Predict Across Species Susceptibility Tool for Rapid Assessment of Protein Conservation

Published on: February 10, 2023

Formulation-Specific Morbilliform Eruption after a Generic Opioid Switch: A Case Discussion.

Charles Mulkey¹, Kelly Ramirez², Tawanda Charumuka²

¹University of Missouri-Kansas City School of Medicine, St. Joseph, Missouri, USA.

Journal of Palliative Medicine

|July 3, 2026

Summary

This summary is machine-generated.

Morbilliform drug eruptions are often mislabeled as opioid allergies. Identifying the specific inactive ingredient, like croscarmellose sodium, in generic medications is crucial for accurate diagnosis and continued pain management.

Keywords:

case report croscarmellose sodium drug eruptions excipients hydrocodone oxycodone

More Related Videos

Assessment of Morphine-induced Hyperalgesia and Analgesic Tolerance in Mice Using Thermal and Mechanical Nociceptive Modalities

Assessment of Morphine-induced Hyperalgesia and Analgesic Tolerance in Mice Using Thermal and Mechanical Nociceptive Modalities

Published on: July 29, 2014

Related Experiment Videos

Last Updated: Jul 4, 2026

Demonstration of the Sequence Alignment to Predict Across Species Susceptibility Tool for Rapid Assessment of Protein Conservation

Demonstration of the Sequence Alignment to Predict Across Species Susceptibility Tool for Rapid Assessment of Protein Conservation

Published on: February 10, 2023

Assessment of Morphine-induced Hyperalgesia and Analgesic Tolerance in Mice Using Thermal and Mechanical Nociceptive Modalities

Assessment of Morphine-induced Hyperalgesia and Analgesic Tolerance in Mice Using Thermal and Mechanical Nociceptive Modalities

Published on: July 29, 2014

Area of Science:

Pharmacology
Clinical Pharmacy
Dermatology

Background:

Morbilliform drug eruptions in palliative care are frequently misdiagnosed as allergies to active pharmaceutical ingredients, particularly opioids.
Generic drug formulations contain diverse inactive excipients that can elicit delayed hypersensitivity reactions.
Inaccurate labeling as "opioid allergy" can restrict essential pain management options for patients.

Purpose of the Study:

To investigate the cause of a morbilliform drug eruption in a palliative care patient following a switch in generic opioid formulation.
To identify the specific inactive excipient responsible for the hypersensitivity reaction.
To emphasize the importance of documenting National Drug Codes (NDCs) for generic medications involved in adverse drug reactions.

Main Methods:

A case study of a patient experiencing a morbilliform eruption after a generic medication switch.
Analysis of National Drug Codes (NDCs) to compare inactive ingredients between different generic formulations.
Clinical observation during a medication washout period and reintroduction of specific drugs.

Main Results:

The patient developed a pruritic morbilliform eruption after switching to a specific oxycodone-acetaminophen formulation (NDC 31722-0951-05).
The eruption resolved during a washout period and the patient tolerated other generic medications (morphine NDC 00406-5118-01, potassium chloride NDC 65862-0987-99).
Croscarmellose sodium, present only in the offending formulation, was identified as the likely causative excipient.

Conclusions:

Delayed hypersensitivity reactions to inactive excipients in generic drugs can mimic active drug allergies.
Documenting the specific National Drug Code (NDC) of implicated generic medications is essential for accurate diagnosis and avoiding inappropriate "drug allergy" labels.
Accurate identification of reaction triggers preserves therapeutic options and ensures access to necessary analgesics.